Sept. 5, 2024 ~ Dr. Anthony Chang, founder and CEO of BAMF Health, the world’s first integrated platform that merges molecular imaging with radiopharmaceutical therapy, talks about theranostics as an emerging concept in cancer care. This approach utilizes molecular imaging to locate and identify tumors, determining if a patient is a suitable match for specific treatments and the appropriate dosage. This intelligence-based method aims for precision medicine, eliminating trial and error.